Microplastics: A New Cardiovascular Risk Factor

By Erik Goldman

The presence of microplastics in carotid atheromas is comparable to diabetes in terms of raising the risk for stroke and myocardial infarction, according to a new study published in the New England Journal of Medicine. (Image: Ukrolenochka/Shutterstock)

The presence of micro- or nano-plastic particles in carotid atheromas significantly raises the risk of myocardial infarction, stroke, or death from any cause within 3 years.

That’s the blunt conclusion of a new multi-center study headed by researchers at the Department of Advanced Medical & Surgical Science, University of Campania, Naples, and involving more than 250 at-risk patients undergoing carotid endarterectomy.

Micro- and nanoplastics (MNPs), defined as plastic particles smaller than 5 mm and 1,000 nm respectively, result from the mechanical breakdown of larger plastic objects. MNPs are increasingly found in air, water, soil, and food worldwide.

[ ...Read More ]

Featured Articles

Eczema: A Holistic Approach

Written by Janet Gulland, Contributing Writer

Eczema is seldom life-threatening, but it can have profoundly detrimental impact on the people it affects. Clinicians who can bring a holistic, root-cause approach to this common condition can make a big difference in the lives of their patients. “Roughly 20 million Americans have eczema. It’s a huge population. Patients are desperate for help, and […]

[ ...Read More ]

Fraudulent Research Floods Nutrition Field, Corroding Credibility

Written by Erik Goldman

Good medical practice is based on trust. Patients trust that practitioners are knowledgeable, and that they put their knowledge in service of their patients’ best interests. In turn, practitioners trust that clinical researchers run their studies honestly, and that the editors and peer-reviewers of the medical journals carefully scrutinize the papers they receive, sift out […]

[ ...Read More ]

HPC Video

Natural Alternatives to Ozempic

Written by Erik Goldman

GLP-1 receptor agonists like Ozempic and Wegovy have rapidly become some of the most widely prescribed drugs for weight loss and metabolic disorders.

While they can sometimes be valuable aids in helping people normalize their weight and their glucose metabolism, the mechanism of action for these drugs can have some unhealthy consequences.

Many people are now looking for alternative ways of boosting endogenous GLP-1 release.

In this free webinar, we’ll discuss the four main issues with Ozmepic and other GLP-1 drugs, and we’ll propose several natural alternatives, including: Berberine, R-lipoic acid and BrocElite® sulforaphane.

We’ll cover:

  • The four main health down-sides associated with Ozempic
  • The potential role of Berberine in weight management
  • The benefits R-lipoic acid and weight loss
  • The microbiome-modulating benefits of BrocElite® broccoli sulforaphae.

Sponsored by: MARA LABS

[ ...Read More ]